Replies to @alamogal635- Good morning. I have never had the option of immunotherapy- Here is a start https://www.mayo.edu/research/centers-programs/discovery-translation-labs-cancer-research/focus-areas/immunotherapy

← Return to FDA Expands Use Of Keytruda for NSCLC

Discussion

Lung Cancer | Last Active: May 6, 2019 | Replies (12)

Comment receiving replies

@merpreb

@alamogal635- Good morning. I have never had the option of immunotherapy- Here is a start https://www.mayo.edu/research/centers-programs/discovery-translation-labs-cancer-research/focus-areas/immunotherapy

Jump to this post

Replies to "@alamogal635- Good morning. I have never had the option of immunotherapy- Here is a start https://www.mayo.edu/research/centers-programs/discovery-translation-labs-cancer-research/focus-areas/immunotherapy"

alamogal635 | @alamogal635 | May 4, 2019

@merpreb Thank you for the information. Always happy to learn more!

VIEW AND REPLY